BPC-157 is a stable 15-residue gastric-juice-derived peptide with one of the most-cited tissue-research literatures of the modern era.
BPC-157 (Body Protection Compound-157) is a 15-residue synthetic peptide derived from a partial sequence of human gastric juice protein. Its notable stability under acidic conditions is one reason it is the most-cited stable gastric peptide in research literature.
Structure
- Sequence: GEPPPGKPADDAGLV
- 15 residues, no disulfide bridges.
- Average mass ~1419.5 Da.
Published research signalling
In-vitro and animal-model literature describes engagement of VEGFR2, nitric-oxide and growth-factor pathways relevant to tissue and vascular research. Findings are observational in those models and do not establish outcomes in humans.
- Batch identifier and synthesis date traceable to the lot record
- HPLC purity ≥98% (typically ≥99% for peptides under 30 residues)
- LC-MS confirmed monoisotopic or average mass within ±0.5 Da of theoretical
- Counterion identity and content (acetate or trifluoroacetate) reported
- Bacterial endotoxin and residual solvents per the analytical method
Research use only. All information on this page is provided strictly for in-vitro and laboratory research reference. Nothing in this article is medical, therapeutic, dosing, or performance advice for human or veterinary use.
